Australia’s medicine industry has called on the Abbott Government to negotiate a five-year strategic agreement after reaching an in-principle deal with the Pharmacy Guild of Australia to ensure access to the best Pharmaceutical Benefits Scheme.
Tim James, chief executive of Medicines Australia, said the sector is seeking certainty from the government after more than A$3 billion ($2.4 billion) in budget savings.
Mr James said: "While Medicines Australia is yet to see the detail of the Pharmacy Guild agreement, the apparent 23% increase in funding will provide certainty for pharmacists and ensure patients are able to have prescriptions filled in much the same way as they always have. Like the Guild, our members are seeking certainty from the Australian government.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze